181 related articles for article (PubMed ID: 10503801)
21. Chronic heart failure and the quality of life.
Alhaddad IA
N Engl J Med; 1999 May; 340(19):1511-2. PubMed ID: 10328721
[No Abstract] [Full Text] [Related]
22. Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
Feldman AM; Becker LC; Llewellyn MP; Baughman KL
Am Heart J; 1988 Sep; 116(3):771-7. PubMed ID: 3046278
[TBL] [Abstract][Full Text] [Related]
23. Dealing with missing outcome data in randomized trials and observational studies.
Groenwold RH; Donders AR; Roes KC; Harrell FE; Moons KG
Am J Epidemiol; 2012 Feb; 175(3):210-7. PubMed ID: 22262640
[TBL] [Abstract][Full Text] [Related]
24. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis.
Gong B; Li Z; Yat Wong PC
J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1415-25. PubMed ID: 26275522
[TBL] [Abstract][Full Text] [Related]
25. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
26. The role of digitalis in the treatment of heart failure.
Demers C; McKelvie RS; Yusuf S
Coron Artery Dis; 1999 Sep; 10(6):353-60. PubMed ID: 10474784
[TBL] [Abstract][Full Text] [Related]
27. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
Hood WB; Dans AL; Guyatt GH; Jaeschke R; McMurray JJ
Cochrane Database Syst Rev; 2004; (2):CD002901. PubMed ID: 15106182
[TBL] [Abstract][Full Text] [Related]
28. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
29. Statistical considerations in the intent-to-treat principle.
Lachin JM
Control Clin Trials; 2000 Jun; 21(3):167-89. PubMed ID: 10822117
[TBL] [Abstract][Full Text] [Related]
30. Chronic heart failure and the quality of life.
Pritzker MR
N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
[No Abstract] [Full Text] [Related]
31. Quinolinone derivatives in the management of congestive heart failure.
Feldman AM; Strobeck JE
Coron Artery Dis; 1994 Feb; 5(2):107-11. PubMed ID: 8180742
[No Abstract] [Full Text] [Related]
32. Meta-analysis of morbidity and mortality in five exercise capacity trials evaluating ramipril in chronic congestive cardiac failure.
Lubsen J; Chadha DR; Yotof YT; Swedberg K
Am J Cardiol; 1996 Jun; 77(14):1191-6. PubMed ID: 8651094
[TBL] [Abstract][Full Text] [Related]
33. Joint modeling of outcome, observation time, and missingness.
Kenward MG; Rosenkranz GK
J Biopharm Stat; 2011 Mar; 21(2):252-62. PubMed ID: 21390999
[TBL] [Abstract][Full Text] [Related]
34. Treatment of missing data in follow-up studies of randomised controlled trials: A systematic review of the literature.
Sullivan TR; Yelland LN; Lee KJ; Ryan P; Salter AB
Clin Trials; 2017 Aug; 14(4):387-395. PubMed ID: 28385071
[TBL] [Abstract][Full Text] [Related]
35. A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment.
Inoue M; Hori M; Yasuda H; Takishima T; Sugimoto T; Sasayama S; Sakurai T; Nonogi H; Kodama K; Kusukawa R
Cardiovasc Drugs Ther; 1987 Aug; 1(2):169-75. PubMed ID: 3154320
[TBL] [Abstract][Full Text] [Related]
36. Digoxin in heart failure.
Chadwell M; French L
J Fam Pract; 1997 May; 44(5):442. PubMed ID: 9152256
[No Abstract] [Full Text] [Related]
37. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
[TBL] [Abstract][Full Text] [Related]
38. Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial.
Lubsen J; Just H; Hjalmarsson AC; La Framboise D; Remme WJ; Heinrich-Nols J; Dumont JM; Seed P
Heart; 1996 Sep; 76(3):223-31. PubMed ID: 8868980
[TBL] [Abstract][Full Text] [Related]
39. Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinan.
Massie BM; Shah NB; Pitt B; Packer M
Am Heart J; 1996 Jul; 132(1 Pt 1):130-6. PubMed ID: 8701855
[TBL] [Abstract][Full Text] [Related]
40. Treatment policy estimands for recurrent event data using data collected after cessation of randomised treatment.
Roger JH; Bratton DJ; Mayer B; Abellan JJ; Keene ON
Pharm Stat; 2019 Jan; 18(1):85-95. PubMed ID: 30406948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
